Bio-Rad Laboratories (BIO-B) Common Equity (2009 - 2026)
Bio-Rad Laboratories (BIO-B) reported Common Equity of $6.9 billion for Q1 2026, up 2.57% year-over-year from $6.7 billion in Q1 2025, and down 8.08% on a QoQ basis from $7.5 billion in Q4 2025.
Bio-Rad Laboratories (BIO-B) has 18 years of Common Equity data on file, last reported at $6.9 billion in Q1 2026.
- Quarterly Common Equity rose 2.57% year-over-year to $6.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.9 billion (up 2.57% YoY) and the FY2025 annual result came in at $7.5 billion, up 13.46% from the prior year.
- Common Equity slipped to $6.9 billion in Q1 2026 per BIO-B's latest filing, from $7.5 billion in the prior quarter.
- Across five years, Common Equity topped out at $10.2 billion in Q1 2022 and bottomed at $6.6 billion in Q4 2024.
- The 5-year median for Common Equity is $8.4 billion (2023), against an average of $8.1 billion.
- The widest annual swing landed in 2022, when Common Equity plunged 44.71%; it then rose 13.46% in 2025.
- Tracing BIO-B's Common Equity over 5 years: stood at $9.6 billion in 2022, then fell by 9.09% to $8.7 billion in 2023, then declined by 24.85% to $6.6 billion in 2024, then rose by 13.46% to $7.5 billion in 2025, then slipped by 8.08% to $6.9 billion in 2026.
- Per Business Quant, the three latest BIO-B Common Equity figures stand at $6.9 billion (Q1 2026), $7.5 billion (Q4 2025), and $6.7 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 48.99 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.68 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.20 Bn |
| 10 | Bio-Rad Laboratories | - | - | 309.40 Mn | 6.85 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.85 Bn |
| Dec 31, 2025 | 7.45 Bn |
| Sep 30, 2025 | 6.74 Bn |
| Jun 30, 2025 | 7.13 Bn |
| Mar 31, 2025 | 6.68 Bn |
| Dec 31, 2024 | 6.57 Bn |
| Sep 30, 2024 | 7.49 Bn |
| Jun 30, 2024 | 6.78 Bn |
| Mar 31, 2024 | 9.05 Bn |
| Dec 31, 2023 | 8.74 Bn |
| Sep 30, 2023 | 8.42 Bn |
| Jun 30, 2023 | 8.45 Bn |
| Mar 31, 2023 | 9.76 Bn |
| Dec 31, 2022 | 9.62 Bn |
| Sep 30, 2022 | 8.48 Bn |
| Jun 30, 2022 | 8.95 Bn |
| Mar 31, 2022 | 10.20 Bn |
| Dec 31, 2021 | 13.69 Bn |
| Sep 30, 2021 | 15.33 Bn |
| Jun 30, 2021 | 11.59 Bn |
| Mar 31, 2021 | 10.61 Bn |
| Dec 31, 2020 | 9.89 Bn |
| Sep 30, 2020 | 8.83 Bn |
| Jun 30, 2020 | 7.35 Bn |
| Mar 31, 2020 | 6.29 Bn |
| Dec 31, 2019 | 5.76 Bn |
| Sep 30, 2019 | 5.13 Bn |
| Jun 30, 2019 | 5.49 Bn |
| Mar 31, 2019 | 4.86 Bn |
| Dec 31, 2018 | 4.02 Bn |
| Sep 30, 2018 | 4.90 Bn |
| Jun 30, 2018 | 4.64 Bn |
| Mar 31, 2018 | 4.49 Bn |
| Dec 31, 2017 | 2.93 Bn |
| Sep 30, 2017 | 2.85 Bn |
| Jun 30, 2017 | 2.81 Bn |
| Mar 31, 2017 | 2.71 Bn |
| Dec 31, 2016 | 2.58 Bn |
| Sep 30, 2016 | 2.70 Bn |
| Jun 30, 2016 | 2.61 Bn |
| Mar 31, 2016 | 2.54 Bn |
| Dec 31, 2015 | 2.49 Bn |
| Sep 30, 2015 | 2.43 Bn |
| Jun 30, 2015 | 2.36 Bn |
| Mar 31, 2015 | 2.20 Bn |
| Dec 31, 2014 | 2.18 Bn |
| Sep 30, 2014 | 2.18 Bn |
| Jun 30, 2014 | 2.25 Bn |
| Mar 31, 2014 | 2.23 Bn |
| Dec 31, 2013 | 2.19 Bn |
| Sep 30, 2013 | 2.12 Bn |
| Jun 30, 2013 | 2.07 Bn |
| Mar 31, 2013 | 2.03 Bn |
| Dec 31, 2012 | 274.53 Mn |
| Sep 30, 2012 | 1.93 Bn |
| Jun 30, 2012 | 1.85 Bn |
| Mar 31, 2012 | 1.84 Bn |
| Dec 31, 2011 | 198.69 Mn |
| Sep 30, 2011 | 1.69 Bn |
| Jun 30, 2011 | 1.73 Bn |
| Mar 31, 2011 | 1.61 Bn |
| Dec 31, 2010 | 1.54 Bn |
| Sep 30, 2010 | 1.42 Bn |
| Jun 30, 2010 | 1.29 Bn |
| Dec 31, 2009 | 1.28 Bn |